Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

Lessons from a pandemic – holistic strategy in the time of coronavirus

COVID-19 has delivered a scenario where developing the strategy for any brand is a challenge

- PMLiVE

Is there such a thing as the new normal? Or is it simply the ‘here and now’?

By Chris Grimes-Crompton

The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence

By Michael Phillips

- PMLiVE

The great reset of frontline HCP relationships

By Madelaine Allen

- PMLiVE

Equipping our people leaders to drive an inclusive organisation

By Mary O’Reilly (pictured) and Nikki O’Hanlon

- PMLiVE

Listen, learn and lift off

By Danny Buckland

- PMLiVE

Virtually present: how to hear every voice in a hybrid setting

By Shaun Beedle

- PMLiVE

Let them eat peanut butter on toast – why HCPs value familiarity over something new

By Kirsty Mead

- PMLiVE

Sanofi’s Rezurock results show positive patient outcomes

Pooled analysis of chronic graft-versus-host disease treatment demonstrates organ clinical responses correlated with meaningful changes

regeneron headquarters

Regeneron set to acquire Checkmate for approximately $250m

The deal is expected to be finalised in mid-2022

- PMLiVE

Sanofi begins construction on the first of two Evolutive Vaccine Facilities in Singapore

The two sites aim to improve pandemic preparedness and will have an estimated cost of $1.3bn over the next five years

- PMLiVE

Ad tracking: the end of the road?

As digital marketers, we’ve been closely monitoring the privacy debates between Apple, Facebook and Google over the last two years.

11 London

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links